A potent photoreactive general anesthetic with novel binding site selectivity for GABAA receptors.

[1]  M. Mihovilovic,et al.  GABAA Receptor Ligands Often Interact with Binding Sites in the Transmembrane Domain and in the Extracellular Domain—Can the Promiscuity Code Be Cracked? , 2020, International journal of molecular sciences.

[2]  K. Miller,et al.  Binding site location on GABAA receptors determines whether mixtures of intravenous general anaesthetics interact synergistically or additively in vivo , 2019, British journal of pharmacology.

[3]  R. Macdonald,et al.  A structural look at GABAA receptor mutations linked to epilepsy syndromes , 2019, Brain Research.

[4]  D. C. Chiara,et al.  Identifying Drugs that Bind Selectively to Intersubunit General Anesthetic Sites in the α1β3γ2 GABAAR Transmembrane Domain , 2019, Molecular Pharmacology.

[5]  S. Forman,et al.  Monod-Wyman-Changeux Allosteric Shift Analysis in Mutant α1β3γ2L GABAA Receptors Indicates Selectivity and Crosstalk among Intersubunit Transmembrane Anesthetic Sites , 2019, Molecular Pharmacology.

[6]  Jasenko Zivanov,et al.  GABAA receptor signalling mechanisms revealed by structural pharmacology , 2019, Nature.

[7]  D. C. Chiara,et al.  Inhibitable photolabeling by neurosteroid diazirine analog in the β3-Subunit of human hetereopentameric type A GABA receptors. , 2019, European journal of medicinal chemistry.

[8]  W. Stec,et al.  Cryo-EM structure of the human α1β3γ2 GABAA receptor in a lipid bilayer , 2019, Nature.

[9]  Jasenko Zivanov,et al.  GABAA receptor signalling mechanisms revealed by structural pharmacology , 2019, Nature.

[10]  W. Sieghart,et al.  International Union of Basic and Clinical Pharmacology. CVI: GABAA Receptor Subtype- and Function-selective Ligands: Key Issues in Translation to Humans , 2018, Pharmacological Reviews.

[11]  U. Rudolph,et al.  An Emerging Circuit Pharmacology of GABAA Receptors. , 2018, Trends in pharmacological sciences.

[12]  S. Forman,et al.  Tryptophan and Cysteine Mutations in M1 Helices of &agr;1&bgr;3&ggr;2L &ggr;-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site , 2016, Anesthesiology.

[13]  K. Miller,et al.  Mapping General Anesthetic Sites in Heteromeric &ggr;-Aminobutyric Acid Type A Receptors Reveals a Potential For Targeting Receptor Subtypes , 2016, Anesthesia and analgesia.

[14]  B. Orser,et al.  Altered expression of δGABAA receptors in health and disease , 2015, Neuropharmacology.

[15]  R. Eckenhoff,et al.  Multiple Propofol-binding Sites in a γ-Aminobutyric Acid Type A Receptor (GABAAR) Identified Using a Photoreactive Propofol Analog*♦ , 2014, The Journal of Biological Chemistry.

[16]  K. Miller,et al.  Human α1β3γ2L gamma‐aminobutyric acid type A receptors: High‐level production and purification in a functional state , 2014, Protein science : a publication of the Protein Society.

[17]  U. Rudolph,et al.  GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. , 2014, Annual review of pharmacology and toxicology.

[18]  Edward H. Smith,et al.  A propofol binding site on mammalian GABAA receptors identified by photolabeling , 2013, Nature chemical biology.

[19]  D. C. Chiara,et al.  Specificity of Intersubunit General Anesthetic-binding Sites in the Transmembrane Domain of the Human α1β3γ2 γ-Aminobutyric Acid Type A (GABAA) Receptor*♦ , 2013, The Journal of Biological Chemistry.

[20]  D. Raines,et al.  Allyl m-trifluoromethyldiazirine mephobarbital: an unusually potent enantioselective and photoreactive barbiturate general anesthetic. , 2012, Journal of medicinal chemistry.

[21]  D. C. Chiara,et al.  Mapping general anesthetic binding site(s) in human α1β3 γ-aminobutyric acid type A receptors with [³H]TDBzl-etomidate, a photoreactive etomidate analogue. , 2012, Biochemistry.

[22]  S. Husain,et al.  The Location and Nature of General Anesthetic Binding Sites on the Active Conformation of Firefly Luciferase; A Time Resolved Photolabeling Study , 2012, PloS one.

[23]  D. Raines,et al.  p-(4-Azipentyl)propofol: a potent photoreactive general anesthetic derivative of propofol. , 2011, Journal of medicinal chemistry.

[24]  K. Miller,et al.  High‐level expression and purification of Cys‐loop ligand‐gated ion channels in a tetracycline‐inducible stable mammalian cell line: GABAA and serotonin receptors , 2010, Protein science : a publication of the Protein Society.

[25]  R. Pearce,et al.  m-Azipropofol (AziPm) a Photoactive Analogue of the Intravenous General Anesthetic Propofol , 2010, Journal of medicinal chemistry.

[26]  S. Forman,et al.  γ-Amino Butyric Acid Type A Receptor Mutations at β2N265 Alter Etomidate Efficacy While Preserving Basal and Agonist-dependent Activity , 2009, Anesthesiology.

[27]  R. Olsen,et al.  GABAA receptors: Subtypes provide diversity of function and pharmacology , 2009, Neuropharmacology.

[28]  Werner Sieghart,et al.  International Union of Pharmacology. LXX. Subtypes of γ-Aminobutyric AcidA Receptors: Classification on the Basis of Subunit Composition, Pharmacology, and Function. Update , 2008, Pharmacological Reviews.

[29]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[30]  U. Rudolph,et al.  Mutational analysis of molecular requirements for the actions of general anaesthetics at the γ-aminobutyric acidA receptor subtype, α1β2γ2 , 2003, BMC pharmacology.

[31]  R. Olsen,et al.  2-(3-Methyl-3H-diaziren-3-yl)ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate: a derivative of the stereoselective general anesthetic etomidate for photolabeling ligand-gated ion channels. , 2003, Journal of Medicinal Chemistry.

[32]  U. Rudolph,et al.  Contribution of the α1-GABAA receptor subtype to the pharmacological actions of benzodiazepine site inverse agonists , 2002, Neuropharmacology.

[33]  N L Harrison,et al.  General anesthetic potencies of a series of propofol analogs correlate with potency for potentiation of gamma-aminobutyric acid (GABA) current at the GABA(A) receptor but not with lipid solubility. , 2001, The Journal of pharmacology and experimental therapeutics.

[34]  P. Whiting,et al.  The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Y. Kita,et al.  The partial molar volumes of anesthetics in lipid bilayers. , 1981, Biochimica et biophysica acta.

[36]  R James,et al.  Synthesis, biological evaluation, and preliminary structure-activity considerations of a series of alkylphenols as intravenous anesthetic agents. , 1980, Journal of medicinal chemistry.

[37]  C. Colton,et al.  Depression of glutamate-mediated synaptic transmission by benzyl alcohol. , 1977, Canadian journal of physiology and pharmacology.

[38]  E. Pardon,et al.  Structure of the human alpha1beta3gamma2 GABA-A receptor in a lipid bilayer , 2019 .

[39]  R. Olsen.  Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes. , 2015, Advances in pharmacology.

[40]  M. Akabas,et al.  Defining the propofol binding site location on the GABAA receptor. , 2004, Molecular pharmacology.